Citius Pharmaceuticals, Inc.

CTXR Stock Healthcare Biotechnology
$0.60
-0.03 (-4.28%)
Price as of Aug 28, 2026 market close

Performance

1 Month
-4.7%
3 Months
-8.1%
YTD
-22.5%
1 Year
-56.1%

Price return, based on split- and dividend-adjusted closing prices.

Risk

Volatility 1-year annualized
112.6%
Largest decline max drawdown, since Aug 2025
-73.6%
Risk-adjusted return Sharpe ratio, 1-year
-0.17

Own CTXR?

See how CTXR contributes to your portfolio's return, allocation, and risk.

7-day free trial, then $9/month.